Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause.
Céline GérardJean-François ArnalMaud JostJonathan DouxfilsFrançoise LenfantCoralie FontaineRené HoutmanDavid F ArcherRobert L ReidRogerio A LoboUlysse GaspardHerjan J T Coelingh BenninkMitchell D CreininJean-Michel FoidartPublished in: Expert review of clinical pharmacology (2022)
Extensive studies have elucidated the properties of E4 that underlie its favorable safety profile. While classical estrogens (such as estradiol) exert their actions via both activation of nuclear and membrane estrogen receptor α (ERα), E4 presents a specific profile of ERα activation: E4 binds and activates nuclear ERα but does not induce the activation of membrane ERα signaling pathways in specific tissues. E4 has a small effect on normal breast tissue proliferation and minimally affects hepatic parameters. This distinct profile of ERα activation, uncoupling nuclear and membrane activation, is unique.